Cardiotoxicity of anticancer drugs and radiotherapy in patients with hematologic malignancies and solid tumors
Cardioncology has emerged as a new field at the intersection of cardiology and oncology. Despite the fact that improving efficiency of antitumor treatment increased the survival of oncological hematological patients, the long-term cardiovascular consequences of this treatment have become more clinic...
Saved in:
| Main Authors: | L. M. Kogoniya, M. O. Rusanov, V. E. Shikina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01) -
MODERN APPROACHES TO DETECTING EARLY SUBCLINICAL CARDIOTOXICITY INDUCED BY CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
by: A. A. Avalyan, et al.
Published: (2018-09-01) -
Cardiotoxicity of Chemotherapeutic Drugs (Literature Review and Clinical Case Description)
by: Avagimyan Ashot A., et al.
Published: (2019-12-01) -
Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01) -
Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)